HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides.

Saved in:
Bibliographic Details
Title: HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides.
Authors: Mathieu MG; School of Biomedical and Natural Science, Nottingham Trent University, Clifton Lane, Nottingham, NG11 8NS, UK., Knights AJ, Pawelec G, Riley CL, Wernet D, Lemonnier FA, Straten PT, Mueller L, Rees RC, McArdle SE
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2007 Dec; Vol. 56 (12), pp. 1885-95. Date of Electronic Publication: 2007 May 09.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0340-7004 (Print) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0340-7004
DOI:10.1007/s00262-007-0331-2